Maher-Edwards_2015_Alzheimer.Dement.(New York)_1_131

Reference

Title : A 24-week study to evaluate the effect of rilapladib on cognition and cerebrospinal fluid biomarkers of Alzheimer's disease - Maher-Edwards_2015_Alzheimer.Dement.(New York)_1_131
Author(s) : Maher-Edwards G , De'Ath J , Barnett C , Lavrov A , Lockhart A
Ref : Alzheimer's & Dementia: Translational Research & Clinical Interventions , 1 :131 , 2015
Abstract : Maher-Edwards_2015_Alzheimer.Dement.(New York)_1_131
ESTHER : Maher-Edwards_2015_Alzheimer.Dement.(New York)_1_131
PubMedSearch : Maher-Edwards_2015_Alzheimer.Dement.(New York)_1_131
PubMedID:

Related information

Citations formats

Maher-Edwards G, De'Ath J, Barnett C, Lavrov A, Lockhart A (2015)
A 24-week study to evaluate the effect of rilapladib on cognition and cerebrospinal fluid biomarkers of Alzheimer's disease
Alzheimer's & Dementia: Translational Research & Clinical Interventions 1 :131

Maher-Edwards G, De'Ath J, Barnett C, Lavrov A, Lockhart A (2015)
Alzheimer's & Dementia: Translational Research & Clinical Interventions 1 :131